Косметика өндірісі мен технологиясына кіріспе
жүктеу/скачать 16,24 Mb. Pdf көрінісі
|
b436ce0a649361871333ff7a454fb4e8 original.17032999
| J Pharm Sci.
1998;87:1203 – 1208. 74. Ruiz, M. A., Clares, B., Morales, M. E., et al.: Preparation and stability of cosmetic formulations with an anti- aging peptide. J Cosmet Sci . 2007;58:157 – 171. 75. NTP Technical Report on the Photocarcinogenesis Study of Glycolic Acid and Salicylic Acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 Mice), Uploaded: 9/2007, Accessed 9/13/2013 at http://ntp.niehs.nih.gov/ntp/htdocs/ lt_rpts/tr524.pdf 76. FDA: Cosmetics, Product and Ingredient Safety, Selected Cosmetic Ingredients: Alpha Hydroxy Acids in Cosmetics, Last update: 9/13/2013, Accessed 12/30/2013 at http://www.fda.gov/cosmetics/ productandingredientsafety/selectedcosmeticingredients/ ucm107940.htm 77.
Krautheim, A., Gollnick, H.: Transdermal penetration of topical drugs used in the treat- ment of acne. Clin Pharmacokinet . 2003;42:1287 – 1304. 78. CDC: BSE (Bovine Spongiform Encephalopathy, or Mad Cow Disease), Last update: 2/21/2013, Accessed 12/30/2013 at http://www.cdc.gov/ncidod/dvrd/bse/ 79.
Will, R. G., Ironside, J. W., Zeidler, M., et al.: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet . 1996;347:921 – 925. 80. Henry, C., Knight, R.: Clinical features of variant Creutzfeldt-Jakob disease. Rev Med Virol . 2002;(3):143 – 150. 81. FDA: Bovine Spongiform Encephalopathy (BSE) Questions and Answers, Last update: 06/18/2009, Accessed 12/30/2013 http://www.fda.gov/biologics bloodvaccines/safetyavailability/ucm111482.htm 82. White, G. M.: Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol . 1998;39:S34 – S37. 83. Feldman, S. R., Fleischer, A. B.: Role of the dermatologist in the delivery of dermatologic care. Dermatol Clin . 2000;18:223 – 227. 84. Yentzer, B. A., Hick, J., Reese, E. L., et al.: Acne vulgaris in the United States: a descriptive epidemiology. Cutis. 2010;86:94 – 99. 85. Collier, C. N., Harper, J. C., Cafardi, J. A., et al.: The prevalence of acne in adults 20 years and older. J Am Acad Dermatol . 2008;58(1):56 – 59. 86. Kurokawa, I., Danby, F. W., Ju, Q., et al.: Review new developments in our understanding of acne pathogenesis and treatment. Exp Dermatol . 2009;18(10):821 – 832. 87. Thiboutot, D., Gollnick, H., Bettoli, V., et al.: New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Der- matol . 2009;60(5):S1 – 50. 88. Gollnick, H., Cunliffe, W., Berson, D., et al.: Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol . 2003;49(1):S1 – S37. 89. Thielitz, A., Gollnick, H.: Topical retinoids in acne vulgaris update on efficacy and safety. Am J Clin Dermatol . 2008;9(6):369 – 381. 90. Makrantonaki, E., Ganceviciene, R., Zouboulis, C.: An update on the role of the seba- ceous gland in the |